The suppression of the NF-κB signaling pathway, leading to a subsequent reduction in proinflammatory mediators and ROS production, is also regarded as a highly promising therapeutic approach for mitigating the detrimental effects of cerebral ischemia [61]. This evidence concerns the gene NFKB1 and Cerebral ischemia.